BioCentury
ARTICLE | Financial News

Akebia raises $89.3M in follow-on

March 23, 2018 4:24 PM UTC

Akebia Therapeutics Inc. (NASDAQ:AKBA) raised $89.3 million through the sale of 8.5 million shares at $10.50 in a follow-on underwritten by Morgan Stanley. The price is a 10% discount to Akebia's close of $11.68 on Thursday, when the company proposed after market hours to raise $85 million. Akebia was off $1.19 (10%) to $10.49 on Friday...